Australia's largest stock trading and investment forum Australia's #1 stock forum

SAS

Click for more information

0.00%

1.6¢ sky and space company ltd

Ann: December Quarter Activity and Cashflow Report, page-18

First 18 Last

Share
Profile

Follow
Lindso47

791 Posts.

1

02/02/17

10:57

Post #: 22312844
Share

Originally posted by redgie321 ↑

$300k is not much of a buffer when there is still a quarter of salaries, expenses, office fees, etc. that need to be paid for. That stuff isn't paid for in advance.

I am still skeptical about the "fully funded to launch" claim that was rolled out before the CR came to fruition. The reason why I raise this is because if that was the case, then a pre-launch CR was always likely to happen, as I doubt they would have held off until post-launch as: 1) too risky, and 2) they would have ran out of money by then.

I am excited as you all about this company but this is something that is worth discussing.

IMO.

Expand

Well, the concern I raised a few times earlier was about the constant dilution that seems to be happening in favour of the Directors, who seem to also be taking a fair whack of cash from the till. DYOR

SAS Price at posting: 10.3¢ Sentiment: Hold Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

First 18 Last

Add SAS (ASX) to my watchlist